Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04867408 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Endoscopic Severity Image Recognition to Advance Research and Training in Inflammatory Bowel Disease (EVEREST - IBD)

StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. 3 versions Re-verified since May 17, 2022, no change to tracked fieldsv4-v6
  2. Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 0 to 1
    • Start date changed from estimate of Sep 2021 to Sep 17, 2021
    v3
  3. Start date: Jun 2021 to Sep 2021
    • Primary and study completion dates: Jun 2031 to Sep 2031
    v2
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
To develop and train a convolutional neural network to detect and characterize disease severity of inflammatory bowel disease during endoscopy
Trial Details
NCT Number NCT04867408
Lead Sponsor Hull University Teaching Hospitals NHS Trust
Collaborators: Wellcome/EPSRC Centre for Interventional and Surgical Sciences, University College London
Conditions
(from sponsor)		 Inflammatory Bowel Disease 1
Related terms Crohn Disease
Enrollment 4,000 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov